| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
194.000 |
Evidence |
|
| WASPIP |
IPI00552369 |
CSK |
CSK: Tyrosine-protein kinase CSK |
194.000 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
RAP1B |
RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor |
194.000 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
194.000 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
LYN |
LYN: Tyrosine-protein kinase Lyn |
194.000 |
Evidence |
|
| YY1 |
YY1: Transcriptional repressor protein YY1 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
194.000 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
194.000 |
Evidence |
|
| CHEK1 |
CHEK1, CHK1: Serine/threonine-protein kinase Chk1 |
CCNB1 |
Cyclin B1 |
194.000 |
Evidence |
|
| RGS20 |
RGS20, RGSZ1, ZGAP1: Regulator of G-protein signaling 20 |
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
194.000 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
ACTC |
ACTC1, ACTC: Actin, alpha cardiac muscle 1 |
191.000 |
Evidence |
|
| WASPIP |
IPI00552369 |
ACTC |
ACTC1, ACTC: Actin, alpha cardiac muscle 1 |
191.000 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
ACTC |
ACTC1, ACTC: Actin, alpha cardiac muscle 1 |
191.000 |
Evidence |
O
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SKIIP |
SNW1, SKIIP, SKIP: SNW domain-containing protein 1 |
190.000 |
Evidence |
|
| RPL3 |
RPL3, OK/SW-cl.32: 60S ribosomal protein L3 |
RPL8 |
RPL8: 60S ribosomal protein L8 |
189.000 |
Evidence |
|
| RPL8 |
RPL8: 60S ribosomal protein L8 |
RPS3 |
RPS3, OK/SW-cl.26: 40S ribosomal protein S3 |
189.000 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
189.000 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
189.000 |
Evidence |
|
| LSM1 |
LSM1, CASM: U6 snRNA-associated Sm-like protein LSm1 |
SNRPE |
SNRPE: Small nuclear ribonucleoprotein E |
188.000 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
188.000 |
Evidence |
|
| PSMC2 |
PSMC2, MSS1: 26S protease regulatory subunit 7 |
PSMD1 |
PSMD1: 26S proteasome non-ATPase regulatory subunit 1 |
188.000 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
CRKL |
CRKL: Crk-like protein |
187.000 |
Evidence |
O
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
187.000 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
CRKL |
CRKL: Crk-like protein |
187.000 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
186.000 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
185.000 |
Evidence |
|
-